Synthesis Capital
Synthesis Capital is a London-based, FCA-regulated venture capital firm managing $300M+ in assets and focused exclusively on seed-to-Series-C food technology companies developing alternative proteins, fermentation, and synthetic fat platforms to replace animal products.
- Company typePrivate
- Founded2020
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Synthesis Capital does
Synthesis Capital LLP is a London-based, FCA-regulated venture capital firm founded in 2020 that invests exclusively in food technology companies from seed through Series C. The firm manages over $300M in assets under management, claims 14+ years of investing experience at the leading edge of food technology, and focuses on technologies that replace animal products across the food supply chain — spanning cultivated meat, plant-based proteins, precision and continuous fermentation, synthetic fats, and cell-line screening.
The firm's product is a single investment platform (Synthesis Capital Fund I LP) deployed across approximately 10 disclosed portfolio companies, including Equinom, Hyfé, Redefine Meat, Savor, Pow.Bio, New Culture, Upside Foods, Culture Biosciences, Perfect Day, and Triplebar. Synthesis Capital typically leads or co-leads Series A and B rounds, partners with high-profile co-investors (Temasek, Abu Dhabi Growth Fund, Breakthrough Energy Ventures, The Production Board), and provides hands-on post-investment support including board leadership and ESG integration. The firm operates with fewer than 10 employees, is co-led by Managing Partner Costa Yiannoulis and Partner Rosie Wardle, and maintains the Guernsey Green Fund designation and UN PRI signatory status as core institutional credibility markers.
Synthesis Capital's revenue model follows the standard venture capital structure: recurring management fees charged on committed capital under investment advisory agreements, supplemented by performance-based carried interest tied to fund returns. The firm does not sell technology products and generates no transactional product revenue; the underlying asset base (AUM), LP composition, and fund performance cycle are the principal value drivers. Distribution and deal sourcing occur through founder networks, co-investor syndicates, and direct outreach, with thought-leadership content and conference presence supporting top-of-funnel brand building.
Synthesis Capital firmographics
Firmographics- Name
- Synthesis Capital
- Legal name
- Synthesis Capital LLP
- Website
- https://synthesis.capital
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Synthesis Capital is a London-based, FCA-regulated venture capital firm managing $300M+ in assets and focused exclusively on seed-to-Series-C food technology companies developing alternative proteins, fermentation, and synthetic fat platforms to replace animal products.
- Ownership category
- akta.pro rank
Synthesis Capital industry classification
Industry- Product category
- Venture Capital (Food Technology)
- NAICS
- Other Financial Investment Activities (5239)
- akta.pro primary industry
- Late-Stage Venture Capital (Series C+) (FSANAAAC)
- akta.pro secondary industry
- Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)
Keywords
Where Synthesis Capital is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Synthesis Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Fund Management Fees: As a venture capital firm managing over $300M in assets under management, Synthesis Capital generates revenue through management fees charged on committed capital under its investment advisory agreements. These fees support the firm's operations and investment activities.
- Carried Interest (Performance Fees): The firm operates a long-term carried interest incentive plan for eligible team members after 12 months of tenure, indicating performance-based compensation tied to investment returns. Synthesis Capital's investment strategy targets strong financial returns alongside positive environmental impact.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Synthesis Capital product offering
Product offeringCore offering
Synthesis Capital is a London-based venture capital firm that invests in food technology companies from seed to Series C, with a thematic focus on platforms that replace animal-derived products (alternative proteins, cultivated meat, precision fermentation, and biomanufacturing). The firm manages over $300M in assets under management, leads and co-leads Series A and B rounds, and provides hands-on post-investment support including board leadership, governance, and ESG integration. Revenue is generated through fund management fees on committed capital and carried interest on investment performance.
Product overview
Synthesis Capital is a venture capital firm operating as a single unified investment platform rather than a multi-product company. The firm manages $300M+ in assets under management and focuses on leading and co-leading Series A and B funding rounds in food technology companies. Rather than offering distinct product modules, Synthesis Capital provides investment services to its portfolio companies including strategic direction guidance, industry partnership development, and commercialization support. The firm's investment thesis centers on companies that replace animal products across the food supply chain, with portfolio companies including Equinom (computational breeding), Hyfé (carbon waste valorization), Redefine Meat (plant-based meat), Savor (synthetic fats), Pow.Bio (continuous fermentation), New Culture (animal-free dairy), Upside Foods (cultivated meat), Culture Biosciences (bioreactor services), Perfect Day (precision fermentation dairy), and Triplebar (cell screening).
Differentiator
Problem solved
Functional benefit
Products and services
- Synthesis Capital Investment Services Venture capital investment services to food technology founders and their companies, providing seed to Series C capital, board leadership, governance, and hands-on strategic and ESG support, with over $300M in assets under management.
Quantifiable outcome
- Synthesis Capital Fund I LP has been designated as a Guernsey Green Fund by the GFSC.
- +1 more outcomes
Companies that use Synthesis Capital
Customer profileSegments2 records
Ideal customer profiles2 records
Synthesis Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Synthesis Capital partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- FrieslandCampina IngredientscoreTriplebar announced a partnership in January 2023 with global ingredients giant FrieslandCampina to co-develop and scale up the production of ingredients essential to human nutrition via precision fermentation. Triplebar and FrieslandCampina produce microbial cells via fermentation methodologies to create proteins with a much smaller land, water, and energy footprint than traditional livestock.
- Umami BioworkscoreIn early 2023, Triplebar partnered with cultivated seafood platform company Umami Bioworks to co-develop optimized cell lines suitable for large-scale production of cultivated seafood, starting with Japanese eel. The partnership leverages Triplebar's Hyper-Throughput screening platform to improve the fitness and performance of cell lines without the need for genetic modification.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Synthesis Capital competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key highlights6 records
Customer concentration
Synthesis Capital social profiles
Digital presenceSynthesis Capital compliance and trust
Trust signalCompliance2 records
Synthesis Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Synthesis Capital leadership team
Management profileNumber of profiles
Profiles2 records
Synthesis Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Synthesis Capital M&A and investment
M&A and investmentM&A
Investments12 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Synthesis Capital
What does Synthesis Capital do?
Synthesis Capital is a London-based venture capital firm that invests in food technology companies from seed to Series C, with a thematic focus on platforms that replace animal-derived products (alternative proteins, cultivated meat, precision fermentation, and biomanufacturing). The firm manages over $300M in assets under management, leads and co-leads Series A and B rounds, and provides hands-on post-investment support including board leadership, governance, and ESG integration. Revenue is generated through fund management fees on committed capital and carried interest on investment performance.
Is Synthesis Capital a public or private company?
Synthesis Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Synthesis Capital founded?
Synthesis Capital was founded in 2020. It employs 1 to 10 people.
Where is Synthesis Capital based?
Synthesis Capital is headquartered in London, United Kingdom, in the Europe region.
How does Synthesis Capital make money?
Two revenue lines are on record. Fund Management Fees are the primary driver. The others are carried Interest (Performance Fees).
Does Synthesis Capital have an API?
No public API is recorded for Synthesis Capital.
What industry is Synthesis Capital in?
Synthesis Capital's product category is Venture Capital (Food Technology). Its primary akta.pro industry code is FSANAAAC, Late-Stage Venture Capital (Series C+), with a secondary code of FSANAAAA, Early-Stage Venture Capital (Pre-Seed/Seed). Its NAICS code is 5239.